The Insides Company And GD Medical Announce Distribution Agreement For The Netherlands And Belgium

GD Medical Pharma BV has been appointed as the distributor for The Insides™ Company's chyme reinfusion solutions in the Netherlands and Belgium.
The Insides Company's award-winning flagship product, The Insides™ System, is a patient managed therapy that enables restoration of intestinal continuity, allowing patients to recommence oral feeding and significantly improve clinical outcomes.
Garth Sutherland, CEO of The Insides Company, said, "The Insides Company is delighted to be working with GD Medical, an established and patient centric medical distributor who share our vision for providing best in class therapies for patients with severe intestinal failure."
Roel Claassen, Managing Director of GD Medical said, “We are honored to start this partnership with The Insides Company and believe our two companies are a great fit! GD Medical aims to bring added value to patients and health care providers with service, knowledge, and education. We strive to introduce innovative products to the market that really have an added value for the patient, and we believe the Insides System fully meets those criteria.”
Spark: New Report Sets Out Outcomes-Led Approach To Lift Rural Connectivity Using The Right Mix Of Technologies
Bill Bennett: Fixed Voice Rules Head For Deregulation
UN Department of Global Communications: United Nations Proposes New Global Dashboard To Measure Progress Beyond GDP
Banking Ombudsman Scheme: Fraud Check Delays Well Worth The Inconvenience, Says Banking Ombudsman
Asia Pacific AML: NZ’s Financial Crime Gap - Beyond The 'Number 8 Wire' Mentality
Westpac New Zealand: Kiwi Households Adapting Despite Widespread Cost Pressure Concerns, Westpac Survey Shows

